Immucell (ICCC) Other Non-Current Assets (2010 - 2026)

Immucell (ICCC) has reported Other Non-Current Assets for 17 consecutive years, with $31658.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Other Non-Current Assets fell 40.96% year-over-year to $31658.0; the trailing twelve-month figure through Jun 2026 stood at $31658.0 (down 40.96% YoY), and the FY2025 full-year result was $37686.0, up 12.94% from the prior year.
• Other Non-Current Assets eased to $31658.0 in Q2 2026 per ICCC's latest filing, from $37686.0 in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $14.0 million in Q4 2022 and bottomed at $22999.0 in Q1 2022.
• Historically, Other Non-Current Assets has averaged $866056.5 across 5 years, with a median of $44345.0 in 2025.
• The sharpest annual moves came in 2022 and 2023: Other Non-Current Assets jumped 53488.96% in 2022, then sank 99.59% in 2023.
• Over 5 years, Other Non-Current Assets stood at $14.0 million in 2022, then tumbled by 99.59% to $57655.0 in 2023, then plunged by 42.12% to $33368.0 in 2024, then increased by 12.94% to $37686.0 in 2025, then declined by 16.0% to $31658.0 in 2026.
• According to Business Quant data, Other Non-Current Assets over the past three periods registered $31658.0, $37686.0, and $44345.0 for Q2 2026, Q4 2025, and Q3 2025 respectively.